Chemical activators of C6orf165 engage various cellular pathways to facilitate its activation. Forskolin is known to directly stimulate adenylate cyclase, thereby increasing intracellular cAMP levels. Elevated cAMP can subsequently activate protein kinase A (PKA), which in turn can phosphorylate C6orf165, leading to its activation within the cell. Similarly, 8-Bromo-cAMP, a cAMP analog, activates PKA, suggesting a parallel route to the activation of C6orf165 via phosphorylation. Ionomycin and A23187, both acting as calcium ionophores, raise intracellular calcium levels. This increase in calcium can activate calcium-dependent protein kinases, which may target C6orf165 for phosphorylation and activation. Thapsigargin, by inhibiting the SERCA pump, also causes a rise in intracellular calcium, potentially resulting in the activation of similar calcium-dependent kinases that could target C6orf165.
Phorbol 12-myristate 13-acetate (PMA), a well-known activator of protein kinase C (PKC), may phosphorylate and activate C6orf165 as part of PKC's broad signaling actions. Anisomycin activates stress-activated protein kinases, which could also phosphorylate C6orf165, suggesting a mechanism of activation through cellular stress pathways. Zaprinast, through inhibition of phosphodiesterases, increases cGMP levels, which may lead to the activation of protein kinase G (PKG), potentially resulting in the phosphorylation and consequent activation of C6orf165. Spermine NONOate, by releasing nitric oxide, activates guanylate cyclase, elevating cGMP levels, providing yet another pathway to PKG-mediated activation of C6orf165. Bisindolylmaleimide I, although primarily a PKC inhibitor, can under specific conditions paradoxically activate PKC, which may then phosphorylate and activate C6orf165. Lastly, Okadaic Acid, by inhibiting protein phosphatases, could maintain C6orf165 in a phosphorylated and thus active state, by preventing its dephosphorylation. Each of these chemicals, through their unique interactions within cellular signaling pathways, can culminate in the functional activation of C6orf165, showcasing the diversity of mechanisms that converge on this single protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which may phosphorylate and activate C6orf165 in signal transduction pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium, potentially activating calcium-dependent protein kinases that could phosphorylate C6orf165. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the SERCA pump leading to increased intracellular calcium which may activate kinases that phosphorylate C6orf165. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcium ionophore that raises intracellular calcium levels, potentially activating kinases that could phosphorylate C6orf165. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
cAMP analog that activates PKA which may lead to phosphorylation and activation of C6orf165. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $103.00 $245.00 | 8 | |
Inhibits PDEs leading to increased cGMP levels which may activate PKG, potentially phosphorylating and activating C6orf165. | ||||||
Spermine NONOate | 136587-13-8 | sc-202816 sc-202816A | 5 mg 25 mg | $52.00 $192.00 | 5 | |
Releases NO which activates guanylate cyclase increasing cGMP levels, potentially leading to PKG-mediated activation of C6orf165. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates stress-activated protein kinases which may phosphorylate and activate C6orf165. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Inhibitor of PKC that can paradoxically activate PKC under certain conditions, potentially leading to phosphorylation and activation of C6orf165. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases, potentially maintaining C6orf165 in an activated state by preventing dephosphorylation. | ||||||